Link Revealed Between Erectile Dysfunction & SIRI
Researchers found a positive association between the systemic inflammatory response index (SIRI) and erectile dysfunction (ED) in U.S. adults aged 20 years or older, with the highest tertile...
Researchers found a positive association between the systemic inflammatory response index (SIRI) and erectile dysfunction (ED) in U.S. adults aged 20 years or older, with the highest tertile...
Peripheral blood smear examination is one of the basic steps in the evaluation of different blood cells. It is a confirmatory step after an automated complete blood count analysis. Manual mi...
Multiple myeloma (MM) is a common type of blood cancer affecting plasma cells originating from the lymphoid B-cell lineage. It accounts for about 10% of all hematological malignancies and ca...
A cross-sectional study identified the monocyte-to-HDL ratio (MHR) as an indicator of poor endothelial dysfunction in diabetic patients, with each 10% increase in MHR associated with a 35% r...
Thanks to new treatments, more people survive histiocytic neoplasms, but their survival comes with challenges, according to findings published in Blood....
1. In patients with low tumor burden follicular lymphoma (LTBFL): Rituximab maintenance therapy does not improve overall survival in comparison to retreatment at 10 year follow-up. 2. Ritux...
Despite advances in defining diverse somatic mutations that cause myeloid malignancies, a significant heritable component for these cancers remains largely unexplained. Here, we perform rare...
Patients with hematological malignancies received multiple hypodermic injections of recombinant human granulocyte colony-stimulating factor. Procedural pain is one of the most common iatroge...
1. Patients in the primaquine group reported a significant reduction in parasitemia risk at day 63 compared to those in the standard care group. 2. The majority of adverse events were mild-t...
Expanding radical cure indications to patients with P. falciparum through high-dose, short-course primaquine resulted in a five-fold reduction in the risk of subsequent P. vivax parasitemia ...
Expanding radical cure indications to patients with P. falciparum through high-dose, short-course primaquine resulted in a five-fold reduction in the risk of subsequent P. vivax parasitemia ...
To assess the prevalence of chronic neutropenia (CN) and the clinical profile of patients with CN aged up to 18 years, followed in the pediatric hematology, rheumatology, or immunology outpa...
A recent study showed improvements for 5-year overall survival (OS) patients with acquired aplastic anemia (AA) or paroxysmal nocturnal hemoglobinuria (PNH) that experienced clonal evolution...
Thrombosis is common in paroxysmal nocturnal hemoglobinuria (PNH), but physicians must weigh direct oral anticoagulants (DOACs) as a preventive strategy against the risk for bleeding, accord...
In France, even though it occurs only exceptionally in cases of hemopathy, severe hemoptysis in cancer is the leading cause of hemoptysis. Without adequate treatment, in-hospital mortality e...
The use of an immunogenic smart radiotherapy biomaterial (iSRB) for the delivery of anti-CD40 is effective in treating different cancers in animal models. This study further characterizes th...
The allogenic bone marrow transplantation has turned from experimental treatment method into standard therapy of many malignant hematological diseases, autoimmune disorders and immunodeficie...
1. In this case-control study, the use of statins in menopausal women concurrently with hormone therapy (HT) significantly reduced the risk of VTE. 2. The response was dose-dependent, with...
Despite the numerous benefits of effective communication between patients, families, and healthcare professionals, there are still substantial barriers and communication challenges. This stu...
Mobile phones have become a vital part of human life. Due to drastic increase in the number of mobile phone subscribers, exposure to radiofrequency radiation (RFR) emitted from these phones ...
The latest articles and insights from your colleagues in your specialty(ies) of choice.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.